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REPLY 
We read with interest the letter from Drs. Vahlquist and Torma 
concerning our recent paper by Hodam et al [1] and are happy to 
respond to the criticisms they raised about our work and the conclu-
sions we drew from the data. In fact, we are pleased that our work 
has generated a constructive dialogue on the controversial topic of 
whether or not cells express a cell-surface receptor for serum re-
tinol-binding protein (RBP) that mediates the delivery of retinol 
from RBP to the cell. It is now well over 15 years since it was first 
reported that retinal pigment epithelial (RPE) cells contain RBP 
receptors [2]; however, to date no RBP receptor has been purified 
and its biochemical properties characterized. In fact, we believe that 
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it has been very unfortunate that, despite the lack of solid evidence 
for RBP receptors, it is repeatedly implied in the literature that 
cell-surface RBP receptors are important for the uptake of retinol 
from RBP. Therefore, we felt that a careful re-examination of this 
issue of RBP receptors and retinol delivery was certainly warranted 
and believed that cultured keratinocytes, a cell type that responds to 
retinoids, would provide an ideal model system for these studies. 
Thus, about 7 years ago we initiated studies using cultured mouse 
keratinocytes to determine if retinol delivery from RBP to these 
cells involved RBP receptors. In our initial study published in the 
]ID [3] we reported that mouse keratinocytes failed to exhibit high-
affinity receptors for RBP. In the recent paper by Hodam et al [1], 
we used cultured human keratinocytes (HKc) and concluded that 
HKc do not express RBP receptors and that retinol is released from 
RBP into the aqueous phase prior to becoming cell-associated. 
These conclusions are in fact consistent with recent reports that 
demonstrate that retinol is spontaneously and rapidly released from 
RBP [4] and that retinol is transferred from RBP to lipid vesicles [5]. 
We believe that a point by point response to the comments made by 
Vahlquist and Torma is appropriate and will demonstrate that the 
experimental design used in our studies and the conclusions drawn 
from the results are scientifically sound. 
First, the procedures used for the formation and isolation of the 
[3H]retinol-RBP complex used in these studies was questioned. Al-
though, it is not clear to us what is meant by "standard procedures," 
we feel that adding [3H]retinol back to apoRBP generated during 
RBP purification is preferable to adding [3H]retinol to apoRBP 
generated by solvent extraction. Clearly, there is more of a chance 
of generating denatured RBP by exposure to solvent rather than, as 
suggested, from the overnight incubation we used. We are surprised 
that Dr. Vahlquist would question the use of affinity chromatogra-
phy on transthyretin (TTR)-Sepharose as a means for purifying the 
[3H]retinol-RBP complex because it was his procedure we followed 
[6]. Although it is extremely difficult to demonstrate conclusively 
that the site on RBP we labeled with [3H]retinol is identical to that 
labeled in vivo, we have taken great pains to characterize the [3H]re-
tinol-RBP complex and are convinced that it behaves like in vivo 
holoRBP. We have demonstrated by sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and by high-per-
formance liquid chromatography (HPLC) that we have purified 
RBP to homogeneity, thus eliminating the possibility that we are 
labeling other plasma proteins in vitro with [3H]retinol ([3] and 
unpublished results). In addition, we have shown that the [3H]re-
tinol-RBP complex co-chromatographs with unlabeled holoRBP 
on a Mono Q HR5/5 column and have also shown by HPLC that 
100% of the label associated with our RBP chromatographs as all-
trans-retinol [3]. Finally, the [3H]retinol-RBP complex binds to 
immobilized TTR. The "labeling efficiency" of the RBP with 
[3H]retinol was also questioned. Indeed, in some experiments al-
most 100% of the added pH]retinol was recovered bound to the 
RBP. This was, however, not unexpected and, in fact, the incuba-
tion conditions were designed with this intention in mind. Our 
purified RBP preparations exhibited a 330/280 absorption ratio of 
0.56 ± 0.13 indicating about 44% of the RBP was in the apo-form. 
Because our in vitro incubations contained 100 J1.g of RBP (there-
fore about 2 nmol of apo-RBP) and 50 J1.Ci of [3H]retinol (1 nmol) 
there was ample apoRBP to bind all of the added [3H]retinol. 
The second point raised by Vahlquist and Torma regarded the 
fact that our uptake experiments were conducted with [3H]retinol-
RBP complex rather than [3H]retinol-RBP-TTR. We have 
previously shown that TTR has little to no influence on the uptake 
of [3H]retinol from RBP (Table II in [3]). In addition, other reports, 
even those supporting a cell-surface receptor for RBP, have con-
cluded that TTR does not playa role in the interaction between 
RBP and the putative RBP receptor [2,7,8] . The next point of ques-
tion concerned the differences in the concentrations of free [3H]re-
tinol and [3H]retinol-RBP used in the time course of [3H]retinol 
uptake experiments presented in Figs 1 and 2 (this does not apply to 
Fig 3) and whether the expression of the uptake data as the percent 
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of applied radioactivity is appropriate. In raising this concern, what 
Vahlquist and Torma failed to keep in mind is that the kinetics of 
uptake of free [3H]retinol or [3H]retinol from RBP are concentration 
independent (Figs 5 and 6). Therefore, although the absolute amount 
of retinol taken up by the cells is obviously concentration depen-
dent, the kinetics of uptake are not. Thus, the curves illustrated in 
Figs 1 and 2 would remain unchanged if we had simply added 
unlabeled retinol to those incubations containing free [3H]retinol, 
so that the final concentration of retinol was identical to that found 
in the incubations containing [3H]retinol-RBP complex. While 
Vahlquist and Torma prefer to interpret the observed linear kinetics 
of uptake of [3H]retinol from RBP as a "receptor mechanism oper-
ating at non-saturating conditions," this mechanism can be ruled 
out because we failed to observe significant inhibition of [3H]retinol 
uptake from RBP by excess unlabeled holoRBP at concentrations as 
high as those found in serum (50 Ilg/ml, Fig 6). 
We agree with the third point raised by Vahlquist and Torma that 
our findings that free retinol and retinol delivered bound to RBP are 
equipotent in the three biologic responses we measured (Figs 7 -9) 
does not prove that retinol enters the cells via the aqueous phase. The 
experiments were, in fact, never envisioned to prove that point. 
However, we reasoned that retinol delivered from RBP would be 
more potent if an RBP receptor system was operative, because it 
would be delivered in a precise way to the plasma membrane that 
could then enhance its subsequent metabolism to retinoic acid. 
However, no difference in potency was found. In addition, recent 
results have shown that the metabolism of [3H]retinol delivered to 
HKc either free or bound to RBP is the same (J.R. Hodam and K.E. 
Creek, unpublished results). The comment that our results on mod-
ulation of keratin expression are at variance with preliminary unpub-
lished results of c.-o. Bivik and U. Eriksson is irrelevant. First, the 
results reported by Hodam et al [1] are not preliminary but have 
been repeated many times. In addition, the conditions we used 
for the culture of HKc must be very different than those used by 
Bavik and Eriksson because our cells do not express keratin Kl 
(Fig 9). 
In conclusion, we feel that our data strongly support RBP recep-
tor-independent delivery of retinol to HKc. We, of course, cannot 
rule out the possibility that an RBP receptor system may function in 
other cell types, such as RPE cells [9]. However, we have also failed 
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to detect binding of 125I-Iabeled RBP to cultured human RPE cells 
(R. Hunt and K. E. Creek, unpublished results). 
KimE. Creek 
John R. Hodam 
Phaedria St. Hilaire 
Department of Chemistry and Biochemis~ry 
University of South Caroltna 
Columbia, South Carolina, U.S.A. 
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Epidermal Interleukin lex Functional Activity and Interleukin 8 
Immunoreactivity Are Increased in Patients with Cutaneous T-Cell Lymphoma 
To the Editor: 
In their recent paper [1], Hansen et al have claimed that epidermal 
interleukin 1 (IL-l) ex functional activity is increased in cutaneous 
T-cell lymphoma (CTCL). This implies that the authors have di-
rectly measured IL-l biologic activity in lesional and control epi-
dermal samples. A closer look at their data shows that they have 
obtained epidermal cell suspensions from the roofs of suction blis-
ters, have cultured these in serum-containing medium for 48 h, 
then measured IL-lex and IL-1P levels in culture supernatants by 
enzyme-linked immunosorbent assay (ELISA). In this protocol, 
higher IL-lex immunoreactivity was present in samples from CTCL 
lesions than normal controls. This data is not the result of the direct 
measurement of IL-l in epidermal samples, and we believe caution 
should be exercised in extrapolating it to the in vivo state, especially 
as the authors' immunohistochemical data seemed to show little 
difference in staining between lesional and control samples. Further-
more, the authors have only bioassayed CTCL culture supernatants, 
thereby confirming the presence of IL-l biologic activity. They 
have not reported the results of quantitative bioassays, nor compared 
activity in CTCL and control supernatants. Their claim that epider-
malIL-lex functional activity is increased in CTCL must therefore be 
held open to question. 
We wish to refer the authors to our/revious work, which they 
have not cited and which was publishe in the dermatologic litera-
ture some months before the submission date of their manuscript 
[2]. In this work we sampled mycosis fungo ides (MF) lesions and 
clinically uninvolved skin by using a chamber method, and mea-
sured IL-l activity directly in these samples by a specific bioassay. 
IL-l activity in lesional samples was significantly lower than in con-
trols, a finding which, interestingly, matches what has been shown 
